Search

everythinglearnresearchcommunity

for

Search:↓

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Araliadiol protects skin cells from damage by boosting antioxidant defenses.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Gentamicin-loaded exosomes improve healing of infected diabetic wounds in mice.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

BTNL2 helps protect hair follicles from immune attacks.

Targeting specific cell interactions may help treat skin fibrosis.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

A 10-year-old girl with hair and eyelash loss showed significant regrowth after treatment.

Microtrauma techniques like microneedling and PRP can help regrow hair in non-scarring alopecia.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

A gel from stem cells can reduce baldness caused by fluconazole in rats.

Different light affects cell functions and can help treat skin conditions.

ADAM17 could be a potential target for treating PCOS.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Hair shaft miniaturization leads to hair follicle stem cell loss, suggesting Piezo1 as a potential treatment target.

Limbal Mesenchymal Stem Cell Secretome might help heal eye injuries by reducing inflammation and promoting tissue repair.

Women with PCOS may be more susceptible to COVID-19 due to hormonal and psychological factors.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

Oral spironolactone and isotretinoin are effective for treating acne.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

PRP treatment increased hair density, especially in men and younger patients with AGA.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.